A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

Michael Dougan; Masoud Azizad; Bharat Mocherla; Robert L Gottlieb; Peter Chen; Corey Hebert; Russell Perry; Joseph Boscia; Barry Heller; Jason Morris; Chad Crystal; Awawu Igbinadolor; Gregory Huhn; Jose Cardona; Imad Shawa; Princy Kumar; Andra Blomkalns; Andrew C Adams; Jacob Van Naarden; Kenneth L Custer; Jack Knorr; Gerard Oakley; Andrew E Schade; Timothy R Holzer; Philip J Ebert; Richard E Higgs; Janelle Sabo; Dipak R Patel; Matan C Dabora; Mark Williams; Paul Klekotka; Lei Shen; Daniel M Skovronsky; Ajay Nirula

Clinical Infectious Diseases (2022) - Comments
pubmed: 34718468 doi: 10.1093/cid/ciab912 issn: 1058-4838 issn: 1537-6591

Michael Dougan, Masoud Azizad, Bharat Mocherla, Robert L Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Chad Crystal, Awawu Igbinadolor, Gregory Huhn, Jose Cardona, Imad Shawa, Princy Kumar, Andra Blomkalns, Andrew C Adams, Jacob Van Naarden, Kenneth L Custer

Go to article
Go to preprint

Oxford University Press (OUP)